202 related articles for article (PubMed ID: 6323979)
1. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
Rahn KH; Stumpe KO
MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
[No Abstract] [Full Text] [Related]
2. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
Ferguson RK; Vlasses PH; Riley LJ
Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
[No Abstract] [Full Text] [Related]
3. [Captopril (Tensobon) in practical use in hypertension and heart failure].
Philipp T; Lederle RM
MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S15-23. PubMed ID: 6424002
[No Abstract] [Full Text] [Related]
4. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
Lee CL; MacDonald GJ; Walsh WF
Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
[No Abstract] [Full Text] [Related]
5. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
[No Abstract] [Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors.
Dipalma JR
Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
[No Abstract] [Full Text] [Related]
7. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiotensin-converting enzyme: therapeutic implications.
Rotmensch HH; Vlasses PH; Ferguson RK
Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
[No Abstract] [Full Text] [Related]
9. [Current aspects of the clinical effectiveness and tolerance of captopril in the treatment of cardiovascular diseases].
Ol'binskaia LI; Mokhova OV
Ter Arkh; 1984; 56(11):139-42. PubMed ID: 6395426
[No Abstract] [Full Text] [Related]
10. [Captopril inhibits angiotensin converting enzyme. New principles for therapy in hypertension and heart failure].
Ohman KP; Karlberg BE
Lakartidningen; 1981 Nov; 78(45):4039-41. PubMed ID: 6276631
[No Abstract] [Full Text] [Related]
11. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
Guerrera G; Melina D
Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
[No Abstract] [Full Text] [Related]
12. [Angiotensin-converting enzyme inhibition: a pathophysiologically based concept for the therapy of hypertension and heart failure].
Stumpe KO; Overlack A; Kolloch R
Dtsch Med Wochenschr; 1984 Aug; 109(34):1295-9. PubMed ID: 6088205
[No Abstract] [Full Text] [Related]
13. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
Guerrera G; Melina D
Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
[No Abstract] [Full Text] [Related]
14. Captopril: an oral angiotension converting enzyme inhibitor active in man.
Brunner HR; Gavras H; Waeber B; Turini GA; Wauters JP
Arch Int Pharmacodyn Ther; 1980; Suppl():188-212. PubMed ID: 6251762
[No Abstract] [Full Text] [Related]
15. [Treatment of chronic refractory cardiac insufficiency with an inhibitor of converting enzyme. Long-term results].
Charbonnier B; Monpère C; Desveaux B; Cosnay P; Fauchier JP; Brochier M
Ann Cardiol Angeiol (Paris); 1984; 33(4):233-7. PubMed ID: 6087714
[TBL] [Abstract][Full Text] [Related]
16. [Effects of prostaglandins and kinin-kallikrein system in heart failure].
Yui Y; Kawai C
Nihon Rinsho; 1983 Dec; 41(12):2735-9. PubMed ID: 6325759
[No Abstract] [Full Text] [Related]
17. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
Stanek B; Templ H; Pohanka E; Silberbauer K
Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
[No Abstract] [Full Text] [Related]
18. The use of captopril in the management of cardiac failure.
Cleland JG; Dargie HJ; Robertson JI; Ball SG; Hodsman GP
Scott Med J; 1984 Apr; 29(2):129-30. PubMed ID: 6099613
[No Abstract] [Full Text] [Related]
19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
20. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
[No Abstract] [Full Text] [Related]
[Next] [New Search]
